| Original language | English |
|---|---|
| Title of host publication | 2025 ASCO Annual Meeting Abstracts |
| Publication status | Published - 2025 |
| Externally published | Yes |
Fields of science
- 302 Clinical Medicine
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Long-term off-label MAPK inhibitor therapy in children with severe/refractory LCH
- Jean Donadieu
- , Dmitrii Evseev
- , et al.
Research output: Chapter in Book/Report/Conference proceeding › Poster › peer-review